Susi Roger E. 4

What Happened
Roger E. Susi, reported as a 10% owner of IRADIMED CORP (IRMD), sold a total of 7,500 shares in open-market transactions on March 6, 2026. The sales were reported as: 6,300 shares at a weighted-average price of $98.25 (proceeds $618,975) and 1,200 shares at a weighted-average price of $99.12 (proceeds $118,944), for combined proceeds of approximately $737,919. These were sales (not purchases), which are often routine divestitures rather than a bullish signal.

Key Details

• Transaction date: March 6, 2026; Form 4 filed March 9, 2026 (filed within the typical two-business-day Form 4 window).
• Shares sold: 6,300 @ $98.25 (weighted avg) and 1,200 @ $99.12 (weighted avg); total shares = 7,500; total proceeds ≈ $737,919.
• Footnotes:
  • F1: Sales were made under a Rule 10b5-1 trading plan adopted Nov 5, 2025.
  • F2/F3: Each sale block was executed in multiple trades across small price ranges (first block ranged $98.00–$99.00; second block ranged $99.01–$99.22); reported prices are weighted averages and more details can be provided on request.
  • F4: The reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.

Context

• 10b5-1 plan: Sales under an existing 10b5-1 plan are pre-scheduled trades and are typically considered routine — they do not necessarily reflect the insider’s current view of the company.
• 10% owner note: As a 10% owner, Susi is a large shareholder; such holders differ from executive officers but are still subject to Section 16 reporting.
• Interpretation: Sales provide liquidity to the insider; purchases are generally more informative for bullish sentiment. This report is factual disclosure of the trades and does not indicate motive.